OneLAX Docusate Sodium Liquid
CGMP Deviations
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Cause type: Packaging defect
Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
Compare with the code on your package — it is the most precise check available.
Drug: Docusate
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.
CGMP Deviations
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
cGMP Deviations: Products may have microbial contamination.
cGMP Deviations: Products may have microbial contamination.
Failed Stability Specifications
Failed Stability Specifications
Failed Stability Specifications
Failed Stability Specifications
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.